The Compound and Friends cover image

Michael Cembalest Returns

The Compound and Friends

00:00

The Current State of Weight Loss Drugs and Rebranding as Cardiovascular Medications

The speakers discuss the effectiveness of weight loss drugs and the challenges of developing them in pill form. They explore the potential of rebranding these drugs as cardiovascular medications and discuss a study on their effectiveness in reducing cardiovascular risk. The chapter also touches on the differing perspectives between Wall Street and the medical community on the study's results.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app